| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5825325 | Clinical Therapeutics | 2014 | 12 Pages |
Abstract
This cost-effectiveness analysis found that the use of tolvaptan was less expensive and more effective than treatment without tolvaptan in patients with euvolemic or hypervolemic hyponatremia.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Min-Young MS, Hee-Jin MS, Se-Young MS, Hye-Lin MS, Euna PhD, Eui-Kyung PhD,